Tag Archives: Brazil

Petition asks BRICS to triple TB R&D funding

By on .

Global tuberculosis treatment advocates and activists are asking leaders of the five countries that are home to almost half of all tuberculosis illnesses and deaths to triple their funding for research and development of new medicines and technologies to prevent, diagnose, and treat the leading infectious disease killer worldwide, on a petition that will be […]

IDWeek 2016: Brazilian HIV physician describes living with endemic Zika infection

By on .

New Orleans, La – The most disturbing thing about having Zika, Dr. Mauro Schechter said, was pruritus, or severe itching. But severe itching isn’t the right way to describe it, he said at IDWeek’s opening plenary. It felt as if “you have pins coming from inside out, plus itching,” he said. “Maybe it’s a sign […]

A year — or two — of Zika in the Western Hemisphere . . . We’re reading about how pandemic preparedness begins

By on .

One year into the Zika outbreak – “As so often happens in public health, when a disease subsides the control programme dies.” This observation, from part three of the World Health Organization’s accounting of how the Zika virus emerged from obscurity to become an unprecedented global health threat, refers to the shutdown of mosquito control […]

Study finds diversity in costs, support, and implementation of recommended antiretroviral treatment monitoring

By on .

It’s the best way to ensure antiretroviral treatment is working for those getting it, protecting their immune systems and preventing illness and transmission — and the alternative is more costly. Yet a World Health Organization published study of how frequently antiretroviral treatment programs in seven countries across the Americas check their patients’ viral loads and […]

START findings highlight treatment divide

By on .

“It’s just more scientific evidence to back what we’ve been saying for a long time.” Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, announcing the conclusion of the START trial, which began in 2011 to assess “the best time for healthy HIV-infected people to begin antiretrovirals.” The announcement from the National Institute […]